| Description | CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases. |
| molecular weight | 328.39 |
| Molecular formula | C17H16N2O3S |
| CAS | 349438-74-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (152.26 mM) |
| References | 1. Ana MARTÍNEZ GIL, et al. Preparation of substituted benzothiazoles as casein kinase 1 inhibitors for the treatment of human diseases. WO2014114825A1 |